Andere talen Antibe Therapeutics Inc.

Aandelen

ATE

CA0370255097

Beurs gesloten - Toronto S.E. Andere beurzen 17:00:00 16-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,295 ^CAD	0,00%		0,00%	-68,28%

24/04	Antibe Therapeutics Inc. Kondigt ontslag van de Raad van Bestuur aan	CI
09/04	Antibe Therapeutics Inc. Kondigt ontslag van de Raad van Bestuur aan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Antibe Announces Appointment of Receiver	24/04
Antibe Therapeutics Inc. Announces Board Resignations	24/04
ANTIBE PROVIDES UPDATE ON CCAA PROCEEDINGS	22/04
Antibe Therapeutics Seeks Extension of Stay of Proceedings	19/04
Antibe Provides Update on CCAA Proceedings	19/04
Antibe Therapeutics Says the TSX Reviewing a Potential Delisting of its Shares	16/04
Antibe Therapeutics Brief: Announcing TSX Delisting Review	16/04
Antibe Announces TSX Delisting Review	16/04
ANTIBE TO FILE AN APPLICATION FOR AN INITIAL ORDER UNDER COMPANIES CREDITORS ARRANGEMENT ACT	10/04
Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act	10/04
DELETED: Canadian Investment Regulatory Organization Trade Resumption - ATE	09/04
Canadian Investment Regulatory Organization Trading Halt - ATE	09/04
Antibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act	09/04
Antibe Therapeutics Brief: Says To File an Application for an Initial Order Under Companies' Creditors Arrangement Act	09/04
Antibe Therapeutics Inc. Announces Board Resignations	09/04
Toronto Stocks Edge Lower; Ballard Power Rises on Fuel-Cell Order	01/04
Antibe Therapeutics Shares Down on Clinical Hold on Otenaproxesul by U.S. Regulator	01/04
Antibe Therapeutics Brief: Down More Than 50% After Announcing FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance	01/04
Antibe Therapeutics Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance	01/04
Antibe Therapeutics Brief: Announcing FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance	01/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Antibe Therapeutics Inc.

Aandelen

ATE

CA0370255097

Andere talen

Filters